- Report
- October 2025
- 188 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 186 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 198 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 187 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 197 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 180 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 196 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 196 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 190 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 197 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 186 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 180 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 186 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 180 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- October 2025
- 183 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- August 2025
- 188 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- August 2025
- 190 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- August 2025
- 180 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- August 2025
- 191 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP
- Report
- August 2025
- 196 Pages
Global
From €3145EUR$3,545USD£2,730GBP
€3494EUR$3,939USD£3,034GBP

The Genetic Disease market is a subset of the Genomics market that focuses on the diagnosis, treatment, and prevention of genetic diseases. It is a rapidly growing field, driven by advances in technology and the increasing availability of genetic testing. Companies in this market are developing new treatments and therapies for genetic diseases, as well as diagnostic tests and tools to identify and monitor them. They are also researching ways to prevent genetic diseases from occurring in the first place.
Companies in the Genetic Disease market include Illumina, Thermo Fisher Scientific, BGI, Genomic Health, and Invitae. These companies are developing innovative products and services to help diagnose, treat, and prevent genetic diseases. They are also investing in research and development to further advance the field. Show Less Read more